Free Trial

Heron Therapeutics (HRTX) Stock Forecast & Price Target

$3.60
-0.03 (-0.83%)
(As of 06/14/2024 ET)

Heron Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 4 Analyst Ratings

Consensus Price Target

$6.00
66.67% Upside
High Forecast$7.00
Average Forecast$6.00
Low Forecast$5.00
TypeCurrent Forecast
6/16/23 to 6/15/24
1 Month Ago
5/17/23 to 5/16/24
3 Months Ago
3/18/23 to 3/17/24
1 Year Ago
6/16/22 to 6/16/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
2 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$6.00$5.50$7.50$7.50
Forecasted Upside66.67% Upside96.78% Upside238.98% Upside149.67% Upside
Get Heron Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter.

HRTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HRTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Heron Therapeutics Stock vs. The Competition

TypeHeron TherapeuticsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.70
2.50
Consensus RatingBuyModerate BuyHold
Predicted Upside66.67% Upside886.67% Upside12.22% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Recent Analyst Forecasts and Stock Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/13/2024Rodman & Renshaw
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$7.00+91.26%
5/16/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$5.00+66.67%
4/23/2024Capital One Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Chiang
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$6.00+131.66%
7/10/2023Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
O. Brayer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
3/24/2023Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$15.00 ➝ $10.00+384.26%
8/15/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$5.50+2.42%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:15 AM ET.

HRTX Frequently Asked Questions

What is Heron Therapeutics's stock forecast and purchase recommendation?

According to the research reports of 4 Wall Street equities research analysts, the average twelve-month stock price forecast for Heron Therapeutics is $6.00, with a high forecast of $7.00 and a low forecast of $5.00. The consensus rating for Heron Therapeutics stock is Buy based on the current 4 buy ratings for HRTX. Learn more on HRTX's analyst rating history.

Do Wall Street analysts like Heron Therapeutics more than its competitors?

Analysts like Heron Therapeutics more than other "medical" companies. The consensus rating for Heron Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how HRTX compares to other companies.

Does Heron Therapeutics's stock price have much upside?

According to analysts, Heron Therapeutics's stock has a predicted upside of 94.59% based on their 12-month stock forecasts.

What analysts cover Heron Therapeutics?

Heron Therapeutics has been rated by research analysts at Capital One Financial, Needham & Company LLC, and Rodman & Renshaw in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:HRTX) was last updated on 6/15/2024 by MarketBeat.com Staff

From Our Partners